# Single-cell RNAseq Breast Cancer

> **NCT05807516** · — · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 20 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **OTHER:** Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)

## Key facts

- **NCT ID:** NCT05807516
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-14
- **Primary completion:** 2022-12-12
- **Final completion:** 2024-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807516, "Single-cell RNAseq Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05807516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*